Taiwan - Delayed Quote TWD

Sinphar Pharmaceutical Co.,Ltd. (1734.TW)

32.40
+0.45
+(1.41%)
As of 9:37:31 AM GMT+8. Market Open.

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Mr. Zhiwen Li Founder & Chairman 27.37M -- --
Chih-Hsiao Chen Assistant GM, CFO & Spokesperson -- -- --
Hsin Huang Wen Vice GM and Chief R&D Officer -- -- --

Sinphar Pharmaceutical Co.,Ltd.

No. 84, Zhongshan Road
Dongshan Township Zhongshan Village
Yilan City, 269
Taiwan
886 8 0001 5151 https://www.sinphar.com.tw
Sector: 
Healthcare
Industry: 
Biotechnology

Description

Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally. It operates through three segments: Pharmaceuticals, Healthy Food, and Others. The company offers pharmaceutical products, including antineoplastic, ophthalmic, ENT, oral, respiratory system, dermatology, analgesic and NSAIDs, metabolic and nutrient, gastrointestinal, and other products; and healthy food under the Sinphar, DailyCare, Migus, YouBest, and SynCoreBio brands. It also provides moisturizer repair essence, anti aging cream, renewable oi, and UV defence cream under the DYNASKIN brand; serum, revitalizing cream, hygiene, sunblock, sunscreen, and lightening tables under the Yestuner brand; and shower gel and hair shampoo. In addition, the company is involved in the provision of testing and development, as well as product design and manufacturing services. The company was incorporated in 1977 and is based in Yilan City, Taiwan.

Corporate Governance

Sinphar Pharmaceutical Co.,Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

September 4, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers